Quantitative study of [(pF)Phe4,Arg14,Lys15]nociceptin/orphan in FQ-NH2 (UFP-102) at NOP receptors in rat periaqueductal gray slices

European Journal of Pharmacology

Volumn 579, Issue 1-3, 2008, Pages 110-115

  Kuo, Chia Ju ^a   Liao, Yan Yu ^a   Guerrini, Remo ^b   Calo', Girolamo ^c   Chiou, Lih Chu ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b Biotechnology Center   (Italy)

^c Neuroscience Center   (Italy)

Author keywords

Nociceptin orphanin FQ; NOP receptors; Periaqueductal gray; Potassium channels; UFP 101; UFP 102

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; NALOXONE; NOCICEPTIN RECEPTOR; NOCICEPTIN RECEPTOR AGONIST; UFP 101; UFP 102; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; HYPERPOLARIZATION; MESENCEPHALON; NERVE CELL; NONHUMAN; PAIN ASSESSMENT; PATCH CLAMP; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; NEURONS; OPIOID PEPTIDES; PATCH-CLAMP TECHNIQUES; PERIAQUEDUCTAL GRAY; RATS; RATS, WISTAR; RECEPTORS, OPIOID;

EID: 37749038959     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.10.006     Document Type: Article

References (37)

1. Anton B., Fein J., To T., Li X., Silberstein L., and Evans C.J. Immunohistochemical localization of ORL-1 in the central nervous system of the rat. J. Comp. Neurol. 368 (1996) 229-251
2. Arduin M., Spagnolo B., Calo' G., Guerrini R., Carra' G., Fischetti C., Trapella C., Marzola E., McDonald J., Lambert D.G., Regoli D., and Salvadori S. Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha-alpha-dialkylated amino acids. J. Bioorg. Med. Chem. 15 (2007) 4434-4443
3. Behbehani M.M., Jiang M., and Chandler S.D. The effect of [Met]enkephalin on the periaqueductal gray neurons of the rat: an in vitro study. Neuroscience 38 (1990) 373-380
4. Calo' G., Guerrini R., Rizzi A., Salvadori S., and Regoli D. Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br. J. Pharmacol. 129 (2000) 1261-1283
5. Calo' G., Guerrini R., Rizzi A., Salvadori S., Burmeister M., Kapusta D., Lambert D.G., and Regoli D. UFP-101. A peptide antagonist selective for the Nociceptin/orphanin FQ receptor. CNS Drug Rev. 11 (2005) 97-112
6. 15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor. J. Pharmacol. Exp. Ther. 312 (2005) 1114-1123
7. Chieng B., and Christie M.J. Hyperpolarization by opioids acting on mu-receptors of a sub-population of rat periaqueductal gray neurones in vitro. Br. J. Pharmacol. 113 (1994) 121-128
8. 2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray. Br. J. Pharmacol. 128 (1999) 103-107
9. + channels by nociceptin and a mu-opioid in rat periaqueductal grey slices. Naunyn-Schmiedeberg's Arch. Pharmacol. 363 (2001) 583-589
10. + channels in rat periaqueductal gray slices. Neuropharmacology 42 (2002) 987-992
11. + channels and cellular actions of morphine in periaqueductal gray slices of neonatal and adult rats. J. Pharmacol. Exp. Ther. 298 (2001) 493-500
12. Chiou L.C., and Huang L.Y. Mechanism underlying increased neuronal activity in the rat ventrolateral periaqueductal grey by a mu-opioid. J. Physiol. 518 (1999) 551-559
13. + channel activation in rat periaqueductal gray slices. Neuropharmacology 42 (2002) 246-252
14. Chiou L.C., Chuang K.C., Wichmann J., and Adam G. Ro 64-6198 [(1S,3aS)-8-(2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-tri az a-spiro[4.5]decan-4-one] acts differently from nociceptin/orphanin FQ in rat periaqueductal gray slices. J. Pharmacol. Exp. Ther. 311 (2004) 645-651
15. Chiou L.C., Liao Y.Y., Fan P.C., Kuo P.H., Riemer C.R., and Prinssen E.P. Nociceptin/orpahnin FQ peptide receptors: pharmacology and clinical implications. Curr. Drug Targets 8 (2007) 117-135
16. 2 is a competitive antagonist of NOP receptors in the periaqueductal gray. Eur. J. Pharmacol. 515 (2005) 47-53
17. Darland T., Heinricher M.M., and Grandy D.K. Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more. Trends Neurosci. 21 (1998) 215-221
18. Economidou D., Fedeli A., Fardon R.M., Weiss F., Massi M., and Ciccocioppo R. Effect of novel nociceptin/orphanin FQ-NOP receptor ligands on ethanol drinking in alcohol-preferring msP rats. Peptides 27 (2006) 3299-3306
19. Guerrini R., Calo' G., Lambert D.G., Carra G., Arduin M., Barnes T.A., McDonald J., Rizzi D., Trapella C., Marzola E., Rowbotham D.J., Regoli D., and Salvadori S. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands. J. Med. Chem. 48 (2005) 1421-1427
20. + (GIRK) channel. Brain Res. Mol. Brain Res. 45 (1997) 117-126
21. Kuzmin A., Sandin J., Terenius L., and Ogren S.O. Evidence in locomotion test for the functional heterogeneity of ORL-1 receptors. Br. J. Pharmacol. 141 (2004) 132-140
22. Liao Y.Y., Prinssen E.P., Kolczewski S., and Chiou L.C. (+)-5a Compound, a novel non-peptide agonist of NOP receptors, partially activates NOP receptor-mediated potassium channel activation in rat periaqueductal gray slices. 5th Forum of European Neuroscience, A187.4, Vienna, Austria (2006)
23. Mathis J.P., Ryan-Moro J., Chang A., Hom J.S., Scheinberg D.A., and Pasternak G.W. Biochemical evidence for orphanin FQ/nociceptin receptor heterogeneity in mouse brain. Biochem. Biophys. Res. Commun. 230 (1997) 462-465
24. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J.C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., and Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377 (1995) 532-535
25. Mogil J.S., and Pasternak G.W. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol. Rev. 53 (2001) 381-415
26. Mollereau C., Parmentier M., Mailleux P., Butour J.L., Moisand C., Chalon P., Caput D., Vassart G., and Meunier J.C. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 341 (1994) 33-38
27. Montiel J.L., Cornille F., Roques B.P., and Noble F. Nociceptin/orphanin FQ metabolism: role of aminopeptidase and endopeptidase 24.15. J. Neurochem. 68 (1997) 354-361
28. Morgan M.M., Grisel J.E., Robbins C.S., and Grandy D.K. Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ. Neuroreport 8 (1997) 3431-3434
29. NC-IUPHAR. IUPHAR receptor database: opioid receptors (2004). http://www.iuphar-db.org/iuphar-rd/
30. Peluso J., LaForge K.S., Matthes H.W., Kreek M.J., Kieffer B.L., and Gaveriaux-Ruff C. Distribution of nociceptin/orphanin FQ receptor transcript in human central nervous system and immune cells. J. Neuroimmunol. 81 (1998) 184-192
31. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J., and Civelli O. Orphanin FQ: a neuropeptide that activates an opioid like G protein-coupled receptor. Science 270 (1995) 792-794
32. Rizzi D., Bigoni R., Rizzi A., Jenck F., Wichmann J., Guerrini R., Regoli D., and Calo' G. Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues. Naunyn-Schmiedeberg's Arch. Pharmacol. 363 (2001) 551-555
33. Rizzi A., Spagnolo B., Wainford R.D., Fischetti C., Guerrini R., Marzola G., Baldisserotto A., Salvadori S., Regoli D., Kapusta D.R., and Calo' G. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphainin FQ receptor. Peptides 28 (2007) 1240-1251
34. Vaughan C.W., and Christie M.J. Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. J. Physiol. 498 (1997) 463-472
35. Vaughan C.W., Ingram S.L., and Christie M.J. Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J. Neurosci. 17 (1997) 996-1003
36. Werthwein S., Bauer U., Nakazi M., Kathmann M., and Schlicker E. Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro. Br. J. Pharmacol. 127 (1999) 300-308
37. Yaksh T.L., Yeung J.C., and Rudy T.A. Systematic examination in the rat of brain sites sensitive to the direct application of morphine: observation of differential effects within the periaqueductal gray. Brain Res. 114 (1976) 83-103